AhR and PPARα:: antagonistic effects on CYP2B and CYP3A, and additive inhibitory effects on CYP2C11

被引:33
|
作者
Shaban, Z
Soliman, M
El-Shazly, S
El-Bohi, K
Abdelazeez, A
Kehelo, K
Kim, HS
Muzandu, K
Ishizuka, M
Kazusaka, A
Fujita, S
机构
[1] Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci,Toxicol Lab, Kita Ku, Sapporo, Hokkaido 0600818, Japan
[2] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Biochem Lab, Sapporo, Hokkaido 0600818, Japan
[3] Tanta Univ, Fac Vet Med, Dept Biochem & Physiol, Tanta, Egypt
关键词
AhR; PPAR alpha; CYP2B; CYP2C11; CYP3A;
D O I
10.1080/00498250400021804
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that mediates a spectrum of toxic and biological effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin ( TCDD) and related compounds. The peroxisome proliferator-activated receptor alpha (PPAR alpha) is a member of the nuclear receptor super-family of ligand-activated transcription factors and it functions as an obligate heterodimer with retinoid X-receptor alpha RXR alpha. The aim was to investigate whether the negative cross-talk recently proposed by the present authors between AhR and PPAR alpha on CYP4A and CYP1A has any impact on other cytochrome P450 enzymes. Treatment of male Wistar rats with a PPAR alpha ligand clofibric acid (CA) induced CYP2B1/2 and CYP3A proteins, activities, and the mRNA expression of CYP2B1, CYP2B2, CYP3A1 and CYP3A2, and suppressed CYP2C11 protein, activities and mRNA expression. AhR ligand Sudan III (S.III) treatment decreased basal and CA-induced CYP2B, CYP3A and CYP2C11 protein, activities and mRNA expression. To the best of the authors' knowledge, this is the first study showing the presence of mutual effects of AhR and PPAR alpha on CYP2B and CYP3A and an additive inhibitory effect on CYP2C11 in the livers of male rats.
引用
收藏
页码:51 / 68
页数:18
相关论文
共 50 条
  • [41] Exploring QSARs for binding affinity of azoles with CYP2B and CYP3A enzymes using GFA and G/PLS techniques
    Roy, Kunal
    Roy, Partha Pratim
    CHEMICAL BIOLOGY & DRUG DESIGN, 2008, 71 (05) : 464 - 473
  • [42] Temporal kinetics and concentration-response relationships for induction of CYP1A, CYP2B, and CYP3A in primary cultures of beagle dog hepatocytes
    Graham, RA
    Tyler, LO
    Krol, WL
    Silver, IS
    Webster, LO
    Clark, P
    Chen, LF
    Banks, T
    LeCluyse, EL
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2006, 20 (02) : 69 - 78
  • [43] Inhibitory Effects of Continuous Ingestion of Schisandrin A on CYP3A in the Rat
    Li, Wei-Liang
    Xin, Hua-Wen
    Su, Mei-Wei
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 110 (02) : 187 - 192
  • [44] Inhibitory Effects of Danshen components on CYP2C8 and CYP2J2
    Xu, Mei-juan
    Jiang, Li-feng
    Wu, Ting
    Chu, Ji-hong
    Wei, Yi-dan
    Aa, Ji-ye
    Wang, Guang-ji
    Hao, Hai-ping
    Ju, Wen-zheng
    Li, Ping
    CHEMICO-BIOLOGICAL INTERACTIONS, 2018, 289 : 15 - 22
  • [45] Suppression of hepatic CYP3A1/2 and CYP2C11 by cyclosporine is not mediated by altering growth hormone levels
    Lu, SK
    Callahan, SM
    Brunner, LJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (01): : 331 - 337
  • [46] Effects of Strong CYP2C8 or CYP3A Inhibition and CYP3A Induction on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers
    Tugnait, Meera
    Gupta, Neeraj
    Hanley, Michael J.
    Sonnichsen, Daryl
    Kerstein, David
    Dorer, David J.
    Venkatakrishnan, Karthik
    Narasimhan, Narayana
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (02): : 214 - 223
  • [47] Effects of inhibitors of CYP1A and CYP2B on styrene metabolism in mouse liver and lung microsomes
    Carlson, GP
    Hynes, DE
    Mantick, NA
    TOXICOLOGY LETTERS, 1998, 98 (03) : 131 - 137
  • [48] Pronounced induction of CYP4A, CYP2B and CYP3A activity in rats treated with the RXR agonists RWJ-392063 and RWJ-666589
    Krueger, Linda A.
    McMullen, Maggie
    Parkinson, Andrew
    Stahle, Paul
    Streeter, Anthony J.
    DRUG METABOLISM REVIEWS, 2006, 38 : 107 - 107
  • [49] In vivo cimetidine inhibits hepatic CYP2C6 and CYP2C11 but not CYP1A1 in adult male rats
    Levine, M
    Law, EYW
    Bandiera, SM
    Chang, TKH
    Bellward, GD
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 284 (02): : 493 - 499
  • [50] Inhibition of Rat CYP1A2 and CYP2C11 by Honokiol, a Component of Traditional Chinese Medicine
    Li, Jing
    Li, Ming-rui
    Sun, Bao
    Liu, Cheng-ming
    Ren, Jing
    Zhi, Wen-qian
    Zhang, Pei-yu
    Qiao, Hai-ling
    Gao, Na
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2019, 44 (06) : 787 - 796